• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional World ex U.S. Core Equity 2 ETF (NY:DFAX)

29.62 -0.12 (-0.40%)
Streaming Delayed Price Updated: 12:50 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 148,750
Open 29.66
Bid (Size) 29.61 (46)
Ask (Size) 29.62 (9)
Prev. Close 29.74
Today's Range 29.58 - 29.66
52wk Range 23.16 - 30.34
Shares Outstanding 3,010,178
Dividend Yield 4.89%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
Today 9:10 EDT
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate. 
Via Stocktwits
Topics Artificial Intelligence World Trade
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug
July 29, 2025
The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of 13% to 21%. 
Via Stocktwits

Performance

YTD
+19.3%
+19.3%
1 Month
+0.9%
+0.9%
3 Month
+9.9%
+9.9%
6 Month
+16.2%
+16.2%
1 Year
+15.8%
+15.8%

More News

Read More
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence
July 15, 2025
Via Stocktwits
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React
July 14, 2025
Via Stocktwits
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance
July 14, 2025
Via Stocktwits
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report
July 11, 2025
Via Stocktwits
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe
July 08, 2025
Via Stocktwits
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants
July 08, 2025
Via Stocktwits
Topics Death Government
Stellantis Production In Italy Slumps 27% In H1 2025: Union Now Expects Slump In Annual Numbers
July 07, 2025
Via Stocktwits
US Regulator Initiates Recall Query Into Nearly 1.2M Stellantis Ram Trucks: Retail Sentiment Dips
July 07, 2025
Via Stocktwits
Topics Product Recall
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish
July 03, 2025
Via Stocktwits
Stellantis’ US Sales Drop Results In Downgrade At Wolfe, Firm Flags ‘Meaningful Risk’ To 2025, 2026 Earnings
July 02, 2025
Via Stocktwits
Toyota’s US Sales Rise 7.2% In Q2 Despite A Dull June: Here’s What Drove Demand For The Japanese Carmaker
July 01, 2025
Via Stocktwits
Li Auto Stock Drops Pre-Market After EV Maker Lowers Q2 Delivery Outlook: Retail Remains Bullish
June 27, 2025
Via Stocktwits
Restaurant Brands Seizes Full Control Of Burger King China In $158M Deal: Retail Stays Bullish
February 18, 2025
Via Stocktwits
Restaurant Brands International Stock In Focus After Q4 Earnings Beat, Burger King Revamp Plan: Retail Cheers
February 13, 2025
Via Stocktwits
Topics Earnings
Smirnoff Parent Diageo’s Stock In Spotlight After Company Warns of $200M Impact From Trump Tariffs: Retail’s Extremely Bearish
February 05, 2025
Via Stocktwits
Topics Government

Frequently Asked Questions

Is Dimensional World ex U.S. Core Equity 2 ETF publicly traded?
Yes, Dimensional World ex U.S. Core Equity 2 ETF is publicly traded.
What exchange does Dimensional World ex U.S. Core Equity 2 ETF trade on?
Dimensional World ex U.S. Core Equity 2 ETF trades on the New York Stock Exchange
What is the ticker symbol for Dimensional World ex U.S. Core Equity 2 ETF?
The ticker symbol for Dimensional World ex U.S. Core Equity 2 ETF is DFAX on the New York Stock Exchange
What is the current price of Dimensional World ex U.S. Core Equity 2 ETF?
The current price of Dimensional World ex U.S. Core Equity 2 ETF is 29.62
When was Dimensional World ex U.S. Core Equity 2 ETF last traded?
The last trade of Dimensional World ex U.S. Core Equity 2 ETF was at 07/30/25 12:50 PM ET
What is the market capitalization of Dimensional World ex U.S. Core Equity 2 ETF?
The market capitalization of Dimensional World ex U.S. Core Equity 2 ETF is 89.16M
How many shares of Dimensional World ex U.S. Core Equity 2 ETF are outstanding?
Dimensional World ex U.S. Core Equity 2 ETF has 89M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap